Mercer Global Advisors’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.18M | Sell |
104,637
-18,522
| -15% | -$1.45M | 0.02% | 416 |
|
|
2025
Q1 | $8.93M | Buy |
123,159
+1,774
| +1% | +$129K | 0.02% | 389 |
|
|
2024
Q4 | $8.99M | Buy |
+121,385
| New | +$8.99M | 0.02% | 381 |
|
|
2024
Q1 | – | Sell |
-52,934
| Closed | -$4.04M | – | 2060 |
|
|
2023
Q4 | $4.04M | Sell |
52,934
-2,718
| -5% | -$207K | 0.01% | 533 |
|
|
2023
Q3 | $3.86M | Buy |
+55,652
| New | +$3.86M | 0.01% | 508 |
|
|
2023
Q1 | – | Sell |
-43,881
| Closed | -$3.27M | – | 1970 |
|
|
2022
Q4 | $3.27M | Sell |
43,881
-3,837
| -8% | -$286K | 0.02% | 550 |
|
|
2022
Q3 | $3.94M | Sell |
47,718
-1,643
| -3% | -$136K | 0.02% | 445 |
|
|
2022
Q2 | $4.69M | Buy |
49,361
+1,306
| +3% | +$124K | 0.03% | 387 |
|
|
2022
Q1 | $5.66M | Buy |
48,055
+6,728
| +16% | +$792K | 0.03% | 354 |
|
|
2021
Q4 | $5.35M | Buy |
41,327
+2,584
| +7% | +$335K | 0.03% | 356 |
|
|
2021
Q3 | $4.39M | Sell |
38,743
-3,229
| -8% | -$366K | 0.03% | 379 |
|
|
2021
Q2 | $4.35M | Sell |
41,972
-862
| -2% | -$89.3K | 0.03% | 354 |
|
|
2021
Q1 | $3.58M | Sell |
42,834
-2,884
| -6% | -$241K | 0.03% | 374 |
|
|
2020
Q4 | $4.17M | Buy |
45,718
+12,602
| +38% | +$1.15M | 0.05% | 256 |
|
|
2020
Q3 | $2.64M | Buy |
33,116
+1,072
| +3% | +$85.6K | 0.04% | 314 |
|
|
2020
Q2 | $2.22M | Buy |
32,044
+9,364
| +41% | +$647K | 0.04% | 310 |
|
|
2020
Q1 | $1.43M | Buy |
22,680
+11,748
| +107% | +$739K | 0.03% | 381 |
|
|
2019
Q4 | $850K | Sell |
10,932
-594
| -5% | -$46.2K | 0.02% | 564 |
|
|
2019
Q3 | $844K | Sell |
11,526
-264
| -2% | -$19.3K | 0.02% | 536 |
|
|
2019
Q2 | $726K | Sell |
11,790
-3,606
| -23% | -$222K | 0.02% | 560 |
|
|
2019
Q1 | $982K | Buy |
+15,396
| New | +$982K | 0.04% | 421 |
|